URBAN ENVIRONMENT AND CHILDHOOD ASTHMA (URECA)

这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金，因此可能会出现在其他CRISE条目中。列出的机构是针对中心的，而不一定是针对调查员的机构。URECA研究将是一项为期三年的纵向前瞻性评估，从出生开始。这项研究的主要目标是确定市中心儿童在36个月大时反复喘息的免疫学原因。第二个目标是确定与市中心儿童特应性疾病发展相关的免疫学发展模式。其他次要目标是确定与市中心生活相关的环境暴露，这些环境暴露改变了免疫发育，并最终改变了特应性和如上所述的反复喘息的发展。虽然最初的研究将对研究参与者进行为期三年的随访，但样本量(本网站的125名参与者)将足够大，因此，如果研究的初始阶段成功，可以对儿童进行跟踪调查，直到六岁，以评估真正的儿童哮喘的发展。父母有过敏性疾病或哮喘阳性病史的家庭将在出生前登记。母亲的压力和其他环境暴露将在产前进行评估。从出生开始并持续到生命的头三年，儿童将接受血细胞细胞因子反应的纵向评估，以及可能影响细胞因子反应发展的出生后环境影响(感染、过敏原和微生物暴露、压力、室内污染物)以及过敏和哮喘的临床表现(反复喘息)。将定期前往诊所进行体检，以跟踪严重下呼吸道症状的发展和持续情况。预定的探视将与环境评估和灰尘收集的家访(三个月)以及从一岁开始的每年一次的诊所探视相对应。最后，将从研究参与者及其母亲那里获得DNA，以评估与观察到的免疫发育模式的遗传相关性，因为它们与喘息性疾病和哮喘有关。假设：出生时的+干扰素-g反应与3岁时反复喘息的风险成反比。+反复喘息将与IL-13反应发展的异常模式相关：IL-13反应在出生时低，然后在三岁时升高。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The URECA study will be a longitudinal prospective evaluation over a three-year time period, beginning at birth. The primary objective of the study is to establish in inner city children the immunologic causes for the development of recurrent wheezing by 36 months of age. The secondary objective is to identify patterns of immunologic development associated with the development of atopy in inner city children. Other secondary objectives are to identify environmental exposures associated with inner city life that modify immune development, and ultimately, the development of atopy and recurrent wheezing as defined above. Although the initial study will involve a three-year follow-up of study participants, the sample size (125 participants at this site) will be large enough so that, if the initial phases of the study are successful, the children could be followed to the age of six years to assess the development of bona fide childhood asthma. Families with a positive parental history of allergic diseases or asthma will be enrolled prior to birth. Maternal stress and other environmental exposures will be assessed prenatally. Beginning at birth and continuing for the first three years of life, the children will be evaluated longitudinally for blood cell cytokine responses, and for postnatal environmental influences (infections, allergen and microbial exposure, stress, indoor pollutants) that could affect the development of cytokine responses, and for clinical manifestations of allergy and asthma (recurrent wheeze). Periodic clinic visits will occur to perform physical examinations in order to track the development and persistence of significant lower respiratory tract symptoms. Scheduled visits will correspond with the home visit (age three months) for environmental assessment and dust collection, and yearly clinic visits beginning at age one year. Finally, DNA will be obtained from study participants and their mothers to evaluate genetic correlates to the observed patterns of immune development as they relate to wheezing diseases and asthma. Hypotheses: + IFN-g responses at birth will be inversely related to the risk of recurrent wheeze at 3 years of age. + Recurrent wheeze will be associated with an abnormal pattern in the development of IL-13 responses: IL-13 responses will be low at birth, and then elevated by three years of age.